INDEMNIFICATION AGREEMENTIndemnification Agreement • October 6th, 2021 • Thimble Point Acquisition Corp. • Services-health services • Delaware
This INDEMNIFICATION AGREEMENT (this “Agreement”) is dated as of , 20 and is between Pear Holdings Corp., a Delaware corporation (the “Company”), and (“Indemnitee”).
Management Retention AgreementManagement Retention Agreement • October 6th, 2021 • Thimble Point Acquisition Corp. • Services-health services • Massachusetts
This Management Retention Agreement (“Agreement”) is made as of ______ __, 20___ (the “Effective Date”), between Pear Therapeutics, Inc., a Delaware corporation (the “Company”), with offices at 200 State Street, 13th floor, Boston, MA 02109 and __________ (“You”), currently residing at the address set forth below your signature on this Agreement. Capitalized terms not defined when used are defined in Exhibit A hereto.
Certain identified information has been omitted from this exhibit because it is not material and of the type that the registrant treats as private or confidential. [***] indicates that information has been omitted. FIRST AMENDMENT TO CONTRIBUTION AND...Contribution and License Agreement • October 6th, 2021 • Thimble Point Acquisition Corp. • Services-health services • Delaware
This First Amendment to the Contribution and License Agreement for Pharmaceutical FOU (this “First Amendment’) dated February 28, 2018 is by and between The Invention Science Fund I, L.L.C. (“ISF1”), a Delaware limited liability company, and Pear Therapeutics, Inc. (“Licensee”, and with ISF1, the “Parties”), a Delaware corporation.
Certain identified information has been omitted from this exhibit because it is not material and of the type that the registrant treats as private or confidential. [***] indicates that information has been omitted. Contribution and License Agreement...Contribution and License Agreement • October 6th, 2021 • Thimble Point Acquisition Corp. • Services-health services • Delaware
This Contribution and License Agreement (“Agreement’) effective on the Closing Date (defined below) by The Invention Science Fund I, L.L.C. (“ISF1”), a Delaware limited liability company, and Pear Therapeutics, Inc. (“Licensee”), a Delaware corporation.
Certain identified information has been omitted from this exhibit because it is not material and of the type that the registrant treats as private or confidential. [***] indicates that information has been omitted. SECOND AMENDED AND RESTATED SOFTWARE...Software License Agreement • October 6th, 2021 • Thimble Point Acquisition Corp. • Services-health services • Delaware
THIS SECOND AMENDED AND RESTATED SOFTWARE LICENSE AGREEMENT (the “Agreement”) is made as of July 1, 2021(the “Second Amended and Restated Effective Date”) by and between Pear Therapeutics, Inc. (“Pear”), a Delaware corporation having its principal place of business at 200 State Street, 13th Floor, Boston MA 02109, and Red 5 Group, LLC (“Licensor”), a New York limited liability company, having its principal place of business at 15 Grant Road, Hanover, NH 03755. The definitions appear in Exhibit A attached hereto.
Certain identified information has been omitted from this exhibit because it is not material and of the type that the registrant treats as private or confidential. [***] indicates that information has been omitted. ASSIGNMENT, LICENSE & SERVICES AGREEMENTAssignment, License & Services Agreement • October 6th, 2021 • Thimble Point Acquisition Corp. • Services-health services • New York
This ASSIGNMENT, LICENSE & SERVICES AGREEMENT (this “Agreement”) is made by and between PEAR THERAPEUTICS, INC., a Delaware corporation with offices at 745 Atlantic Ave., Boston, MA 02111 (“Pear ”), and BEHEALTH SOLUTIONS, LLC, a Virginia limited liability company with offices at 375 Greenbrier Drive, Charlottesville, VA 22901 (“BeHealth”), effective as of March 24, 2018 (the “Effective Date”), for the purpose of (i) transferring to Pear all of BeHealth’s right, title and interest in and to the Assigned Assets (as defined below), (ii) otherwise granting Pear a license under certain related intellectual property and proprietary rights retained by BeHealth related to the Assigned Assets, and (iii) obtaining BeHealth’s assistance and services in connection with the Assigned Assets after the Effective Date.
